Mediject -MPS 125mg (Methylprednisolone Sodium Succinate Vials) 125mg

Mediject -MPS 125mg contains methylprednisolone sodium succinate, a corticosteroid available in vials for injection. Used to reduce inflammation and immune response in various conditions. Short-term relief for flare-ups and acute symptoms. Store at 15-25°C to maintain potency.

Strength

125mg

Pack Size

Storage

15-25°

Manufacturer / TM Owner

Nitin Lifesciences Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Methylprednisolone sodium succinate is commonly used to treat inflammatory conditions like arthritis, severe allergies, and skin disorders. It may also be prescribed for flare-ups of asthma or lupus. The medication works by suppressing the immune system to reduce swelling and discomfort. Patients often ask what is methylprednisolone sodium succinate used for in acute settings.

Side Effects

This corticosteroid helps reduce inflammation and swelling in the body, providing relief from pain and discomfort. Some users may notice improved mobility or breathing as symptoms subside. Effects vary by individual and condition being treated. Always follow healthcare provider guidance for best results.

Precautions & Warnings

Keep vials refrigerated until use and protect from light. Avoid exposure to extreme temperatures. Do not use if the solution is discolored or contains particles. Discard any unused medication after the recommended timeframe. Consult a healthcare professional before starting treatment.

Avoid Interactions

Corticosteroids like methylprednisolone may interact with blood thinners, diabetes medications, and vaccines. Alcohol use may increase stomach upset or bleeding risk. Inform your doctor about all medications and supplements you take. Certain drugs, such as CYP3A4 inhibitors, can affect how this medication works.

Frequently Asked Questions

It is used to reduce inflammation and immune response in conditions like arthritis, allergies, and asthma flare-ups.

Store vials at 15-25°C and protect from light until ready for use.

It is available by prescription; consult a healthcare provider for proper use.

Possible side effects include increased blood sugar, mood changes, or stomach upset.

Consult a healthcare professional to assess risks and benefits for your situation.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.